The Effect of Azathioprine on Phagocytic Activity and Morphology of Reticulo-Endothelial Organs in Mice

References

• Allison F., Jr, Adcock MarthaH. Impaired leucocytic bactericidal activity resulting from cortisol treatment. Clin. Res. 1962; 10: 212
   Google Scholar
• Benacerraf B., Halpern B.N., Biozzi G., Benos S.A. Quantitative study of the granulopectic activity of the reticulo-endo-thelial system. III: The effect of cortisone and nitrogen mustard on the regenerative capacity of the R.E.S. after saturation with carbon. Brit. J. exp. Path. 1954; 35: 97–106
   PubMedGoogle Scholar
• Berenbaum M.C. Immunosuppressive agents. Brit. med. Bull. 1965; 21: 140–146
   PubMed Web of Science ®Google Scholar
• Berenbaum M.C. Immunosuppressive agents and allogeneic transplantation. J. clin. Path. (Suppl.). 1967; 20: 471–498
   Web of Science ®Google Scholar
• Bilenko M.V. (1968) Comparative results of application of immunodepressive drugs in homotransplantation. Advance in Transplantation. Proceedings of the First International Congress of the Transplantation Society, Paris, 1967, J. Dausset, J. Hamburger, G. Mathé. Munksgaard, Copenhagen, 177–182
   Google Scholar
• Biozzi G., Benacerraf B., Halpern B.N. Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the granulopectic activity of the R.E.S. in relation to the dose of carbon injected. Relationship between the weight of the organs and their activity. Brit. J. exp. Path. 1953; 34: 441–457
   PubMed Web of Science ®Google Scholar
• Burchenal J.H., Ellison RoseR. Symposium on the experimental pharmacology and clinical use of antimetabolites. Part IX. The pyrimidine and purine antagonists. Clin. Pharmacol. Ther. 1961; 2: 523–541
   PubMed Web of Science ®Google Scholar
• Casey T.P. Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice. Clin. exp. Immunol. 1968; 3: 305–312
   PubMedGoogle Scholar
• Clark P.A., Hsia Y.E., Huntsman R.G. Toxic complications of treatment with 6-mercaptopurine. Brit. med. J. 1960; 1: 393–395
   PubMed Web of Science ®Google Scholar
• Clarke D.A., Philips F.S., Sternberg S.S., et al. 6-Mercaptopurine: effects in mouse sarcoma 180 and in normal animals. Cancer Res. 1953; 13: 593–604
   PubMed Web of Science ®Google Scholar
• Clawson B.J., Nerenberg S.T. The effect of large doses of cortisone upon the ability of the reticuloendothelial cells to phagocytose streptococci. J. Lab. clin. Med. 1953; 42: 746–748
   PubMed Web of Science ®Google Scholar
• Crepea S.B., Magnin G.E., Seastone C.V. Effect of ACTH and cortisone on phagocytosis. Proc. Soc. exp. Biol. (N.Y.). 1951; 77: 704–706
   PubMed Web of Science ®Google Scholar
• Dougherty T.F. Effect of hormones on lymphatic tissue. Physiol. Rev. 1952; 32: 379–401
   PubMed Web of Science ®Google Scholar
• Einhorn M., Davidsohn I. Hepatotoxicity of mercaptopurine. J. Amer. med. Assoc. 1964; 188: 802–806
   PubMed Web of Science ®Google Scholar
• Elion GertrudeB., Callahan Sandra, Bieber S., et al. A summary of investigations with 6-[(1-methyl-4-nitro-5-imidazolyl) thio] purine (B.W. 57-322). Cancer Chemother. Rep. 1961; 14: 93–98, No.
   Google Scholar
• Frenkel J.K., Havenhill M.A. The corticoid sensitivity of golden hamsters, rats and mice. Effects of dose, time and route of administration. Lab. Invest. 1963; 12: 1204–1220
   PubMed Web of Science ®Google Scholar
• Gell P. G. H., Hinde IsobelT. The effect of cortisone on macrophage activity in mice. Brit. J. exp. Path. 1953; 34: 273–275
   PubMed Web of Science ®Google Scholar
• Gotjamanos T. Alterations in reticuloendothelial organ structure and function following cortisone administration to mice. J. reticuloendoth. Soc. 1970; 8: 421–433
   PubMedGoogle Scholar
• Gotjamanos T., Gill P.G. Changes in phagocytic activity and morphology of reticuloendothelial organs in mice induced by antilymphocyte serum. Aust. J. exp. Biol. med. Sci. 1970; 48: 461–480
   PubMedGoogle Scholar
• Haugen J., Bassøe H.H., Flood P.R. Phagocytosis in rabbits treated with oxyphenbutazone and cortisone, studied by gold clearance test and electron microscopy. J. reticuloendoth. Soc. 1969; 6: 184–193
   PubMedGoogle Scholar
• Heller J.H. Cortisone and phagocytosis. Endocrinology 1955; 56: 80–85
   PubMed Web of Science ®Google Scholar
• Hill R.B. Fatal fat embolism from steroid-induced fatty liver. New Engl. J. Med. 1961; 265: 318–320
   Web of Science ®Google Scholar
• Hill R.B., Jr., Rowlands D.T., Jr., Rifkind D. Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation. New Engl. J. Med. 1964; 271: 1021–1027
   PubMed Web of Science ®Google Scholar
• Hoehn R.J., Weil R., Simmons R.L. Synergistic and antagonistic actions of immunosuppressive agents with anti-lymphocyte serum. Surg. Forum. 1967; 18: 231–232
   Google Scholar
• Hornnes N., RygÅrd J. Determination of inhibited blood clearance in cortisone-treated mice by the intravenous injection of Au198. Acta radiol. (Stockh.). 1960; 53: 42–48
   PubMed Web of Science ®Google Scholar
• Jeejeebhoy H.F., Rabbat A.G., Vela-Martinez J. Studies on the mode of action of heterologous antilymphocyte plasma (ALP). 3. The effects of 6-mercaptopurine and cortisol on the immunosuppressive properties of ALP. Transplantation 1968; 6: 765–770
   PubMed Web of Science ®Google Scholar
• Krawitt E.L., Stein J.H., Kirkendall W.M., Clifton J.A. Mercaptopurine hepatotoxicity in a patient with chronic active hepatitis. Arch. intern. Med. 1967; 120: 729–734
   PubMedGoogle Scholar
• Lurie M.B., Zappasodi P., Dannenberg A.M., Jr., Swartz IreneB. Constitutional factors in resistance to infection: the effect of cortisone on the pathogenesis of tuberculosis. Science 1951; 113: 234–237
   PubMed Web of Science ®Google Scholar
• McLlvanie S.K., MacCarthy J.D. Hepatitis in association with prolonged 6-mercaptopurine therapy. Blood. 1959; 14: 80–90
   PubMed Web of Science ®Google Scholar
• Magee P.N., Palmer A.A. The absorption of particles from the peritoneal cavity in rats and mice treated with cortisone. Brit. J. exp. Path. 1953; 34: 458–463
   PubMedGoogle Scholar
• Martin S.P., Kerby GraceP. Effect of adrenal hormone overdosage on bacterial removal by the splanchnic viscera. Proc. Soc. exp. Biol. (N.Y.). 1952; 81: 73–75
   PubMed Web of Science ®Google Scholar
• Nicol T., Bilbey D. L. J. Substances depressing the phagocytic activity of the reticulo-endothelial system. Nature (Lond.). 1958; 182: 606
   PubMed Web of Science ®Google Scholar
• Nicol T., Bilbey D. L. J. The effect of various steroids on the phagocytic activity of the reticuloendothelial system. Reticuloendothelial Structure and Function, J.H. Heller. Ronald Press Co., New York 1960; 301–320
   Google Scholar
• Philips F.S., Sternberg S.S., Hamilton L., Clarke D.A. The toxic effects of 6-mercaptopurine and related compounds. Ann. N.Y. Acad. Sci. 1954; 60: 283–296
   PubMedGoogle Scholar
• Rawls W.B., Goldzieher J., Tichner J.B., Baker E. The effect of (1) hypophysectomy alone and (2) hypophysectomy plus various combinations of the steroids and ACTH upon phagocytosis by the reticuloendothelial system of intravenously injected India ink particles. J. Lab. clin. Med. 1954; 44: 512–516
   PubMed Web of Science ®Google Scholar
• Santisteban G.A., Dougherty T.F. Comparison of the influences of adrenocortical hormones on the growth and involution of lymphatic organs. Endocrinology 1954; 54: 130–146
   PubMed Web of Science ®Google Scholar
• Shorter R.G., Spencer R.J., Hallenback G.A. Antilymphoid sera in clinical renal allotransplantation. J. Amer. med. Assoc. 1967; 202: 845–846
   Web of Science ®Google Scholar
• Spain D.M., Molomut N., Haber A. Biological studies on cortisone in mice. Science 1950; 112: 335–337
   PubMed Web of Science ®Google Scholar
• Starzl T.E., Marchioro T.L., Porter K.A., et al. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg. Gynec. Obstet. 1967a; 124: 301–318
   PubMedGoogle Scholar
• Starzl T.E., Porter K.A., Iwasaki Y., . The use of heterologous antilymphocyte globulin in human renal homotransplantation. Ciba Foundation Study Group No., 29 on Antilymphocytic Serum, G. E. W. Wolstenholme, Maeve O'Connor, et al. J & A Churchill Ltd., London 1967b; 4–34
   Google Scholar
• Starzl T.E., Marchioro T.L., Hutchison D.E., et al. The clinical use of antilymphocytic globulin in renal homotransplantation. Transplantation 1967c; 5: 1100–1105
   Google Scholar
• Steinberg H., Webb W.M., Rafsky H.A. Hepatomegaly with fatty infiltration secondary to cortisone therapy: case report. Gastroenterology 1952; 21: 304–309
   PubMed Web of Science ®Google Scholar
• Weil R., Simmons R.L. Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine. Ann. Surg. 1968; 167: 239–245
   PubMed Web of Science ®Google Scholar
• Woodruff M. F. A. Immunosuppression and its complications. Proc. roy. Soc. Med. 1969; 62: 411–416
   PubMedGoogle Scholar